Exhibitors
Abbott
Abbott offers life-changing medical device technologies and solutions that treat diabetes.
Boehringer Ingelheim
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in the two business units Human Pharma and Animal Health.
Janssen
Janssen Pulmonary Hypertension
At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.
Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals is a biopharmaceutical company currently applying unique approaches to gene science based on Nobel Prize-winning technology to discover precise medicines for people with serious, chronic conditions. Using a patient driven approach, we are working to develop innovative medicines to safely and effectively treat disease and improve lives.
Pfizer, Rare Disease
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. The company was established in 1849 in New York by two German immigrants, Charles Pfizer and his cousin Charles F. Erhart.
scPharmaceuticals
We are focused on turning patient care inside out. Our mission is to improve patient lives and reduce healthcare costs by enabling and enhancing outpatient management of acute conditions with innovative therapeutic solutions.
Our goal is to provide targeted solutions for patient populations and disease states where outpatient management will have the greatest impact.
Please visit FUROSCIX.com (https://www.furoscix.com/hcp/) to learn more about our lead product, FUROSCIX (furosemide injection, 80 mg/10 mL), and see if it is right for your patients.
[Justin Davis, [email protected]]
Exhibitor Registration